GlycoShape @glycoshape.org · 25/09/2026Pls note that from now on, in case you use tools that require access to an extended dataset (Level 2), we ask you to acknowledge our terms and conditions. Level 2 conformers are under CC BY-NC-ND 4.0 See glycoshape.org/licensing for details 000
GlycoShape @glycoshape.org · 25/09/2026Refreshed ReGlyco Filter in bioRxiv 🧪(doi.org/10.64898/202...) in view of the upcoming Protein Design Competition on Monday 28/09 🎉🔥 proteinbase.com/competitions... Each week a new target and if it's a glycoprotein, glycoshape.org and ReGlyco Filter can help screen and optimise your binder design 172
GlycoShape @glycoshape.org · 04/09/2026🚨 New version of GlycoShape is now live at glycoshape.org 🥳 Powered by crabWURCS everything runs on your browser and while you save all you ReGlyco work and go back to it whenever you like 😎 Among other new things: new slick drawer, much easier to use, new slick SNFG representations and new layout 1146
GlycoShape @glycoshape.org · 17/07/2026Instead of a thread, we have a blog as a tutorial glycoshape.org/blog For any feedback/questions, please feel free to comment below or to quote, we can see both. Happy reading 😎 020
GlycoShape @glycoshape.org · 30/06/2026Un-crystallisable glyco-complexes anyone? New work led by John Klassen's lab introduces antibody masking-native mass spectrometry (AM-nMS) a spatially resolved assay that allowed us to map glycan binding sites across the SARS-CoV-2 RBD. The results match our MDs! 😜 All details glycoshape.org/blog 131
GlycoShape @glycoshape.org · 19/06/2026At the bottom of the page you'll also find a subscription option where you can sign up for an email notification when a new post is published 🥳 120
GlycoShape @glycoshape.org · 19/06/2026glycoshape.org has now a blog where we discuss (yep you got it) glycans, glycoproteins and fun stuff! Season 1 is out with: Ep01: Why should we care about glycan heterogeneity? Ep02: How can we include glycan heterogeneity in a 3D framework? Ep03: Molecular precision glycoscience: Enter Siglecs 122
GlycoShape @glycoshape.org · 09/06/20268/10 In the absence of a terminal Sia the Gal of core1 engages in an intramolecular interaction with Trp63 of CR6 (pink in Fig.c and insert), which in turns stabilises the direct contact between the linker and the RAP (red) 140
GlycoShape @glycoshape.org · 09/06/20267/10 But what about the effect of hyposialylation of at C6X(3-5)T*C1 (GALNT11) O-glycans? @silviadandrea.bsky.social ran multiple uncorrelated MD simulations to figure this out using the structure of the RAP/CR5-CR6 complex as a model (PDB 2FYL) with sialylated (and not) core1 at C6-AYP-T-C1 130
GlycoShape @glycoshape.org · 09/06/20265/10 SO, does O-glycosylation of CRs influence LRP1 ligand selection and clearance? INDEEDLY it does. O-glycosylation significantly enhances uptake of tau and decreases uptake of Aβ in two cell models, HEK293 and neuroblastoma SH-SY5Y cells ⬇️🤯 131
GlycoShape @glycoshape.org · 09/06/20264/10 CRs are O-glycosylated at C6X(3-5)T*C1 by GALNT11, one of 20 GalNAc-transferases that initiate protein GalNAc-type O-glycosylation. O-glycans are present at 13 CR linkers in LRP1 and are hyposialylated 120
GlycoShape @glycoshape.org · 09/06/20262/10 Background: LRP1 is a l~600 kDa transmembrane receptor that engages > 50 different ligands for clearance from neuronal and cerebrospinal fluid (CSF). How this broad ligand selection is accomplished and how it leads to different cellular responses is unclear 120
GlycoShape @glycoshape.org · 05/06/20267/8 The reflections and analysis in this review are the product of a lot of conversations and reading through the years, but also of practice by the very talented BIOL6105 students (25/26) who test drove the glycoprotein design protocols for one of their assignments 120
GlycoShape @glycoshape.org · 05/06/20266/8 But how can we understand/predict/include glycoheterogeneity in our studies or in the design of glycoprotein biologics? We discuss the hGH design assisted by GlycoShape ⬇️ as an example and recommend the following work when dealing with mucins Chongsaritsinsuk et al, doi.org/10.1038/s414... 230
GlycoShape @glycoshape.org · 05/06/20264/8 Microheterogeneity (a feature not a bug) modulates glycan-dependent structure and function properties with exceptional dynamisms, allowing to tune them as a dial more than a ON/OFF switch, by glycan types conc gradients. This is critical in tuning properties such as immune response 120
GlycoShape @glycoshape.org · 05/06/20262/8 Macroheretogeneity refers to the occupancy of glycan sites. We discuss how the sequence determinants for N-glycosylation, and not other sequon-dependent PTMs, requires ‘beyond the sequon’ regulation of macroheterogeneity for with direct implications into glycoproteins structure and function 120
GlycoShape @glycoshape.org · 05/06/2026Glycoheterogeneity is an aspects of glycobiology that most would class into a category between difficult and intolerable, but @benschulz.bsky.social and us love it! So we wrote a whole review in Current Opinion in Structural Biology on it 🧵1/8 ⬇️ doi.org/10.1016/j.sb... 184
GlycoShape @glycoshape.org · 02/06/20263/4 Accordingly the Van’t Hoff analysis shows that this temperature-enhanced cooperativity is predominantly entropy driven, while the overall gain in binding free energy stands regardless of the order in which the monomers are occupied because of the interlocked architecture 130
GlycoShape @glycoshape.org · 02/06/20262/4 In this work ⬇️ we used variable temperature native MS in combination with T replica exchange (REMD) to study cholera toxin B subunit pentamer (CTB5) reveal how binding to one monomer (cyan/GM1 yellow) triggers the prestructuring of the next adjacent (purple) doi.org/10.1021/acs.... 140
GlycoShape @glycoshape.org · 24/04/2026Daily job count is quite high these days after the release of our case study 1 week ago and of the ReGlyco de novo Binder Design Filter notebook ⬇️ doi.org/10.64898/202... and res. therein So exciting to see a growing number of researcher including glycosylation in their studies! 🎉 #glycotime 🧪 051
GlycoShape @glycoshape.org · 17/04/20266/7 We made a colab notebook demo where users can design ‘mini binders’ against human erythropoietin (hEPO) by integrating GlycoShape with the RFdiffusion3 (RFD3) pipeline (doi.org/10.1101/2025...) from the Institute for Protein Design (IDP) colab.research.google.com/github/Ojas-... 120
GlycoShape @glycoshape.org · 17/04/20264/7 Enabling rotameric freedom (dunbrack.fccc.edu/lab/bbdep2010) refines the filter, yet still flagged 5 designs with irresolvable clashes in the Boltz-2 predicted structures. We rebuild all 5 complexes with the AF3 server (no glycans) and were able to obtain an alternative clear pose only for 1 ⬇️ 120
GlycoShape @glycoshape.org · 17/04/20263/7 We used GlycoShape ReGlyco and the new ReGlyco Rotamer tools to filter in-block the 1,201 results. This exercise flagged 11% of non-binders prior to experiment in approx 3 hrs on a dual-core CPU, a negligible computational overhead 120
GlycoShape @glycoshape.org · 17/04/20262/7 To illustrate this point we chose to filter the results of a recent open competition launched by Adaptyv Bio for the design of binders to the heavily glycosylated Nipah virus glycoprotein (NiV-G). (proteinbase.com/competitions...) which is quite ‘furry’ when expressed in HEK293 cells 120
GlycoShape @glycoshape.org · 30/03/2026Super congratulations to the Siglec (and many other stories) extraordinaire Dr. D'Andrea!!! 👩🎓🎉🥂🍾 A huge thank you to the fantastic examiners Alba Silipo (external) and Trinidad Velasco-Torrijos (internal) for your expert and in-depth examination, which made Silvia's viva a great day to remember 😎 1142
GlycoShape @glycoshape.org · 19/03/2026Super congratulation to Dr Akash Satheesan from the glycoShape team, who graduated officially today with a PhD @maynoothuniversity.ie !! 😎🎓👏🥳🥂 The 🔺-red gown definitely suits you well Akash! 😍 051
GlycoShape @glycoshape.org · 02/03/2026This work is also yet another example of how the chemistry and 3D context helps understanding recognition and binding. What can apparently look similar in 2D can be dramatically different in a 3D context where motions and dynamics are at play! Hope you'll enjoy reading the paper 050
GlycoShape @glycoshape.org · 02/03/2026Finally, we demonstrated that Siglec-6 is a molecular precision tool, recognising not only the epitope with surgical precision, but also the environment where the epitope is found (see ⬇️). This helps rationalise the apparent redundancy of Siglecs as specific receptors to diff sialylated glycans 120
GlycoShape @glycoshape.org · 02/03/2026Duong, Ling, Lara and John used native MS to measure the binding affinity of Siglec-6 to oligosaccharides, GM1os, GM2os and GM3os, and showed that in the absence of the bilayer, all three gangliosides are bound with the same affinity and in a Arg122 dependent manner🔥 😎 120
GlycoShape @glycoshape.org · 02/03/2026Eddie and Matt tested Siglec-6 binding on ganglioside-enriched liposomes and showed that the loss of K126 and W127 determine a complete loss of GM1 binding 🔥, and confirmed that the loss of the canonical Arg122 only decreases binding affinity, in perfect agreement with the 3D model 😎 130
GlycoShape @glycoshape.org · 02/03/2026Silvia's simulations showed that while all epitopes expose Sia for binding, Siglec-6 recognises and binds only GM1 because of a key interaction with the membrane through W127 and K126, which orientates the V-set domain to bind the Sia through Arg122 and the terminal Gal to the C-C' loop 😎 1134
GlycoShape @glycoshape.org · 02/03/2026Silvia designed and ran a 2 years worth of MD simulations to determine how recognition of a very small epitope like GM1 sticking out of the membrane could be recognised and bound specifically by Siglec-6, i.e only GM1, and not GM2 or GM3 which are all very similar... 130
GlycoShape @glycoshape.org · 02/03/2026Siglec-6 is one of 14 human Siglecs, all known to bind Sia with through a conserved (canonical) Arg. In earlier work Eddie, Matt et al (doi.org/10.1038/s414...) determined that in Siglec-6 the canonical Arg is dispensable, loss of R122 decreases but does not eliminate binding. How does this work? 130
GlycoShape @glycoshape.org · 03/01/2026This ⬇️ is screenshot of the Advanced Settings I used to produce the ensemble shown in the picture above, 130
GlycoShape @glycoshape.org · 03/01/2026Happy new year 2026 #glycotime! 🥳 We just introduced some useful options to Re-Glyco Ensemble. In the Advanced Settings you can now select a seed (positive integer) to reproduce structural ensemble of your favourite glycoforms such as the one below that you will see soon in an upcoming paper, 1136
GlycoShape @glycoshape.org · 15/12/2025GlycoShape couldn't have happened without all the hard work, super skillzzz and dedication of our team, current (below) and previous members! 🤩🤩 EF is not the only cat, you can scroll over the photos to discover all others 😍 And key funding from @researchireland.ie (former SFI) FFP🙏 ⬇️🧵 110
GlycoShape @glycoshape.org · 15/12/2025We have used this approach to rebuild hyperglycosylated human EPO (or NESP shown below in the gif) in seconds 🏎️💨 as part of MSci and postgraduate summer schools structure glycoengineering for biologics workshop ⬇️🧵 110
GlycoShape @glycoshape.org · 15/12/2025We have also a new and improved Re-Glyco Ensemble, where you can see through a multiframe (50 to 500 frames from MD) glycan structure view, statistics and corresponding SASA analysis how the protein structure shifts the conformational equilibrium of the glycans ⬇️🧵 110
GlycoShape @glycoshape.org · 15/12/2025We are not only continuing to grow our library, but also continuously perfecting and expanding our tools. Re-Glyco is leading the way 🤩, with improved computational efficiency 🏎️💨 and informative queuing widget and calculation process log ⬇️🧵 120
GlycoShape @glycoshape.org · 15/12/2025To do that we built the largest OA 3D library of glycan structures worldwide 🤯, counting 882 unique glycans complemented by at least 3 conformers each to account for their dynamics, obtained from the analysis of multimicrosecond MD simulations doi.org/10.1038/s415... ⬇️🧵 110
GlycoShape @glycoshape.org · 15/12/2025Since Dec 2023 Glycoshape has progressively built a community of glycoengineers that continues to grow. These scientists recognise that to understand glycoproteins structure and function we need to take into consideration the glycans they have, with their micro and macro heterogeneity 🧵⬇️ 110
GlycoShape @glycoshape.org · 15/12/2025Happy birthday to us! 🥂🎂🥳 We are only 2 yo, but so much #glycotime happened since Dec 2023! ⬇️🧵 We truly appreciate your support, you fabulous glycoengineers around the world and we have so many exciting new tools for you coming up in 2026 to make your 3D glycoforms even better and faster! 🤩 172
GlycoShape @glycoshape.org · 11/12/2025This insight does not substitute MD simulations at all, but can complement it for high throughput as it took us seconds to build the structures you see with Re-Glyco Ensemble, about 30 mins to investigate and run rotameric search, and a whole lot of time to play around with pretty pictures 🤓 ⬇️🧵 110
GlycoShape @glycoshape.org · 11/12/2025Fucosylation does not change that, but it makes the fold less compact as it sits between the a6 arm and the core. The presence of fucose in this case allows the glycan to access all its preferred conformational degrees of freedom around the pocket indicated by a circle ⬇️🧵 130
GlycoShape @glycoshape.org · 11/12/2025We see (with just 50 frames from multimicrosecond MD data available in the database) that the conformation of the non-fucosylated glycan (G44826KU) is restricted by the protein structure. Indeed, the a6 arm (esp with gal and sia) prefers to fold over the core ⬇️🧵 doi.org/10.1093/glyc... 110
GlycoShape @glycoshape.org · 11/12/2025Glycans structure and flexibility is an inherent property of their structure and branching. The conformational equilibrium is only shifted when the protein architecture requires a selection of conformers that complement it best. This appears to be one of those cases 110
GlycoShape @glycoshape.org · 05/12/2025We just did some maintenance and updates to glycoshape.org, ✅ Fancy background with floating SNFG symbols 🤩 ✅ 'Latest Updates' feed from this account on bsky 🤩 ✅ Download PDB with SASA values in Re-Glyco Ensemble 🤩 Check it out! 043
GlycoShape @glycoshape.org · 04/12/2025This unique modification is introduced by the tryptophan C-mannosyltransferase (CMT). The beautiful structure of the C elegans CMT and the reaction are described in the brilliant work of Joël Bloch and coworkers[1]. 110
GlycoShape @glycoshape.org · 04/12/2025For some unique #glycotime: C-man is a rare (but evolutionarily very old[1]) post translational modification of proteins, where the C2 of Trp in W-x-x-W/C sequons are linked to a single man through a C-C bond 🤯 This and its position within the structure stabilises the (unusual for man) 1C4 chair[2] 162
GlycoShape @glycoshape.org · 02/12/20253/3 GlycoShape is an open access library of glycan structures from MD simulations that gives users all the diff structures significantly occupied at equilibrium and tools to reconstruct the target glycoproteins with a single representative conformer (Re-Glyco) or multiple (Re-Glyco Ensemble) 051